Drug firm Unichem Laboratories today reported a 26.33 per cent rise in standalone net profit to Rs 26.10 crore for the quarter ended December 31, mainly on account of robust sales.
The company had posted a net profit of Rs 20.66 crore in the year—ago period, Unichem Laboratories said in a BSE filing.
Its total income on standalone basis from operations also rose to Rs 359.92 crore in the said quarter under as against Rs 309.21 crore a year ago.
Unichem Laboratories has strong presence in therapy areas of cardiology, neurology, orthopedics and anti—infectives.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.